Gene Targeting in Stem Cells from Individuals with Osteogenesis Imperfecta-Reference-Cited by-同舟云学术

Gene Targeting in Stem Cells from Individuals with Osteogenesis Imperfecta

Published:2004-02-20 Issue:5661 Volume:303 Page:1198-1201
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Chamberlain Joel R.¹²³⁴⁵,Schwarze Ulrike¹²³⁴⁵,Wang Pei-Rong¹²³⁴⁵,Hirata Roli K.¹²³⁴⁵,Hankenson Kurt D.¹²³⁴⁵,Pace James M.¹²³⁴⁵,Underwood Robert A.¹²³⁴⁵,Song Kit M.¹²³⁴⁵,Sussman Michael¹²³⁴⁵,Byers Peter H.¹²³⁴⁵,Russell David W.¹²³⁴⁵

Affiliation:

1. Department of Medicine, University of Washington, Seattle, WA 98195–7720, USA.

2. Department of Pathology, University of Washington, Seattle, WA 98195–7720, USA.

3. Department of Biochemistry, University of Washington, Seattle, WA 98195–7720, USA.

4. Department of Orthopaedic Surgery and Unit for Laboratory Animal Medicine, University of Michigan, Ann Arbor, MI 48109–0486, USA.

5. Children's Hospital and Regional Medical Center, Seattle, WA 98105, USA.

Abstract

Adult stem cells offer the potential to treat many diseases through a combination of ex vivo genetic manipulation and autologous transplantation. Mesenchymal stem cells (MSCs, also referred to as marrow stromal cells) are adult stem cells that can be isolated as proliferating, adherent cells from bones. MSCs can differentiate into multiple cell types present in several tissues, including bone, fat, cartilage, and muscle, making them ideal candidates for a variety of cell-based therapies. Here, we have used adeno-associated virus vectors to disrupt dominant-negative mutant COL1A1 collagen genes in MSCs from individuals with the brittle bone disorder osteogenesis imperfecta, demonstrating successful gene targeting in adult human stem cells.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference22 articles.

1. P. H. Byers, in The Metabolic and Molecular Basis of Inherited Disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle, Eds. (McGraw-Hill, New York, 2000), pp. 5241–5286.

2. M. C. Willing, C. J. Pruchno, M. Atkinson, P. H. Byers, Am. J. Hum. Genet.51, 508 (1992).

3. J. Korkkoet al., Am. J. Hum. Genet.62, 98 (1998).

4. R. Hirata, J. Chamberlain, R. Dong, D. W. Russell, Nature Biotechnol.20, 735 (2002).

5. J. Bonadio, K. A. Holbrook, R. E. Gelinas, J. Jacob, P. H. Byers, J. Biol. Chem.260, 1734 (1985).

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal stem cells—role in tuberculosis pathogenesis and persistence;Stem Cells;2024

2. Mesenchymal stem cells in the treatment of osteogenesis imperfecta;Cell Regeneration;2023-02-02

3. Viral Vectors in Transgenic Research: Prospects for the Treatment of CNS Diseases and Gene Therapy;Pacific Medical Journal;2022-03-26

4. Spatial Distribution and Geosimulation of Non-timber Forest Products for Food Security in Conflict Area;The Climate-Conflict-Displacement Nexus from a Human Security Perspective;2022

5. Modern approaches on stem cells and scaffolding technology for osteogenic differentiation and regeneration;Experimental Biology and Medicine;2021-10-14